Grant funding disruptions affect one in 30 clinical trials

Grant funding disruptions affect one in 30 clinical trials

Grant funding disruptions affected about one in 30 trials, according to a research letter published online Nov. 17 in JAMA Internal Medicine.

Navigating Research Disruptions: The Impact of NIH Grant Terminations and the Pharmacist’s Expanding Role

Research funding disruptions at the National Institutes of Health (NIH) impact clinical trials, threatening treatment options for patients and highlighting the critical role of pharmacists in care continuity.